Safety and Effectiveness of Oral
Background. Fusidic acid (FA) is an anti-staphylococcal agent used to treat chronic bone and joint infections (BJI) due to the availability of an oral formulation and its MRSA activity. Though used widely throughout the world for decades, FA is not approved in the USA.
Methods. To evaluate the safety and effectiveness of FA as chronic suppressive therapy in patients with staphylococcal BJI, we enrolled 30 patients in a prospective, single-arm, multi-center study in the USA. Eligible patients had refractory infections that could not be managed surgically and/or had not responded to previous antibiotic treatment. In Part A of the study, all patients received 6 months of oral FA treatment. In the first 1-2 weeks, patients could receive a companion antibiotic. Clinical success was based on lack of need for surgery or additional antibiotics. After all patients completed Part A of the study, an interim analysis was performed. In Part B of the study (ongoing), patients who completed Part A and require continued suppressive therapy may continue to receive FA for a total of 24 months.
Results. Most patients (83%) had orthopedic hardware infections. Therapy was considered successful at the 6-month visit in 18 patients (60%). Microbiological persistence was observed in eight patients, with three cases of decreasing FA susceptibility (including one case of resistance). Among 29 patients who experienced a treatment-emergent adverse event (TEAE), the most frequently reported events were: urinary tract infection (n = 9), peripheral edema/swelling (n = 8), nausea/dyspepsia (n = 7). Seven patients experienced TEAEs related to study drug; mild gastrointestinal disorders were most common. Two treatment-related events (unrelated to therapeutic failure) led to discontinuation of study drug Conclusion. Patients with refractory BJI have few treatment options. In our study, 60% of infections were effectively suppressed for 6 months with FA treatment. The frequency of TEAEs was high, though not unexpected in this population with many chronic diseases. FA was well-tolerated with few patients experiencing treatment-related AEs leading to study drug discontinuation. FA administered chronically as monotherapy may lead to decreasing susceptibility and treatment failure in some patients; thus, combination therapy is warranted for this indication. Thursday, October 4, 2018: 12:30 PM Background. Atlantoaxial joint septic arthritis and superior ophthalmic vein thrombosis (SOVT) are uncommon sequelae of infections. Here, we describe a patient who presented concurrently with two uncommon manifestations of a common pathogen, methicillin-susceptible Staphylococcus aureus (MSSA), and review the associated literature. A 68-year-old man presented to the hospital with a 4-day history of worsening neck pain, right shoulder pain, and one episode of diplopia. He reported left wrist pain and swelling 3 weeks prior to presentation. A whole body 18 F-positron emission tomography scan detected abnormal hypermetabolic activity in the atlantoaxial joint and in the right shoulder ( Figure 1A and B) . Magnetic resonance imaging revealed the presence of right SOVT ( Figure 1C and D) . Blood cultures grew MSSA. He underwent debridement of his right shoulder and was started on intravenous cefazolin. Conservative management of his atlantoaxial septic arthritis was unsuccessful and several weeks into his antibiotic course, he developed right-arm weakness for which he underwent C4 fusion to address atlanto-axial instability.
Methods. We reviewed previous reports describing atlantoaxial septic arthritis (n = 6) and septic ophthalmic vein thrombosis (n = 6).
Results. Previous reports of atlantoaxial septic arthritis detailed clinical presentations of subacute to acute onset of neck pain with fever, five of which were due to S. aureus. Four of the cases required a surgical intervention involving the cervical spine. Previous reports of SOVT describe patients ipsilateral proptosis, ptosis and chemosis. In all six cases, the SOVT developed in concurrence with a head and neck infections. Three cases required surgery or an interventional procedure for source control Two cases recovered completely and three cases improved but with diplopia or permanent loss of vision in the affected eye.
Conclusion. Even with early recognition and prompt initiation of antibiotic therapy, our patient still suffered from long-term sequelae atlantoaxial septic arthritis and SOVT, a testament to the potential for MSSA to cause severe infections. 
